Mega-deals barely pay off for acquirers

摘要

At US$63bn, abbvie's takeover bid for botox maker allergan is one of the largest acquisitions announced so far this year. And JP Morgan, as sole adviser to the target, appears to have secured a good outcome for its client, as the deal values Allergan's shares at a 45% premium to their pre-bid share price.